ArticleJournal of clinical medicine2022

Clinical Utility of Plasma Cell-Free DNA EGFR Mutation Analysis in Treatment-Naïve Stage IV Non-Small Cell Lung Cancer Patients.

Bo-Guen Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.